Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Nanoparticles | 49 | 2023 | 1939 | 7.390 |
Why?
|
RNA, Small Interfering | 19 | 2023 | 3432 | 2.660 |
Why?
|
Nanomedicine | 11 | 2022 | 288 | 2.000 |
Why?
|
Drug Delivery Systems | 18 | 2023 | 2211 | 1.950 |
Why?
|
Nanotechnology | 12 | 2023 | 707 | 1.790 |
Why?
|
Polymers | 15 | 2023 | 1612 | 1.590 |
Why?
|
Drug Carriers | 7 | 2021 | 705 | 1.200 |
Why?
|
Melanins | 2 | 2021 | 289 | 1.130 |
Why?
|
RNA, Messenger | 8 | 2023 | 12761 | 1.120 |
Why?
|
Gene Transfer Techniques | 6 | 2017 | 1203 | 1.050 |
Why?
|
Lipids | 5 | 2021 | 3326 | 0.990 |
Why?
|
RNA | 4 | 2023 | 2716 | 0.940 |
Why?
|
Cancer Vaccines | 3 | 2020 | 1046 | 0.920 |
Why?
|
PTEN Phosphohydrolase | 2 | 2021 | 1114 | 0.910 |
Why?
|
Polyethylene Glycols | 10 | 2021 | 1188 | 0.900 |
Why?
|
Antioxidants | 3 | 2021 | 1665 | 0.860 |
Why?
|
Tumor Suppressor Protein p53 | 3 | 2023 | 2913 | 0.810 |
Why?
|
Neoplasms | 18 | 2021 | 21986 | 0.770 |
Why?
|
Tumor Microenvironment | 5 | 2022 | 3839 | 0.750 |
Why?
|
Nucleic Acids | 1 | 2023 | 187 | 0.730 |
Why?
|
Dendrimers | 1 | 2020 | 71 | 0.680 |
Why?
|
Liver Failure, Acute | 1 | 2021 | 181 | 0.670 |
Why?
|
Mice, Nude | 9 | 2019 | 3600 | 0.620 |
Why?
|
Plaque, Atherosclerotic | 6 | 2024 | 1505 | 0.620 |
Why?
|
Cell Line, Tumor | 19 | 2023 | 16881 | 0.600 |
Why?
|
Hydrogels | 1 | 2023 | 722 | 0.570 |
Why?
|
HeLa Cells | 9 | 2017 | 3096 | 0.550 |
Why?
|
Photochemotherapy | 1 | 2023 | 820 | 0.550 |
Why?
|
RNA Interference | 5 | 2021 | 2834 | 0.530 |
Why?
|
Phospholipids | 3 | 2008 | 784 | 0.500 |
Why?
|
Nanostructures | 5 | 2020 | 546 | 0.500 |
Why?
|
Metal Nanoparticles | 1 | 2018 | 397 | 0.440 |
Why?
|
Atherosclerosis | 9 | 2024 | 3401 | 0.440 |
Why?
|
Robotics | 1 | 2020 | 819 | 0.430 |
Why?
|
Lipid Bilayers | 3 | 2008 | 383 | 0.390 |
Why?
|
Reactive Oxygen Species | 5 | 2023 | 2127 | 0.380 |
Why?
|
Small Molecule Libraries | 1 | 2017 | 723 | 0.380 |
Why?
|
Repressor Proteins | 3 | 2020 | 2976 | 0.370 |
Why?
|
Hydrogen-Ion Concentration | 5 | 2019 | 2496 | 0.370 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2019 | 2056 | 0.360 |
Why?
|
Serum Albumin, Bovine | 2 | 2008 | 322 | 0.360 |
Why?
|
G(M1) Ganglioside | 2 | 2008 | 87 | 0.360 |
Why?
|
Animals | 41 | 2024 | 167718 | 0.340 |
Why?
|
Microscopy, Electron, Transmission | 3 | 2021 | 695 | 0.340 |
Why?
|
Blood Platelets | 1 | 2020 | 2476 | 0.330 |
Why?
|
Macrophages | 8 | 2024 | 5732 | 0.330 |
Why?
|
Biocompatible Materials | 3 | 2019 | 1686 | 0.320 |
Why?
|
Mice | 26 | 2024 | 81066 | 0.320 |
Why?
|
Prostatic Neoplasms | 4 | 2021 | 11057 | 0.320 |
Why?
|
Pharmaceutical Preparations | 4 | 2023 | 1087 | 0.320 |
Why?
|
Phagocytosis | 3 | 2024 | 1532 | 0.320 |
Why?
|
Molecular Imprinting | 1 | 2008 | 12 | 0.320 |
Why?
|
Apoptosis | 8 | 2024 | 9466 | 0.310 |
Why?
|
Cholera Toxin | 2 | 2008 | 559 | 0.300 |
Why?
|
Immunotherapy | 3 | 2022 | 4641 | 0.300 |
Why?
|
Biological Products | 1 | 2017 | 903 | 0.300 |
Why?
|
Particle Size | 4 | 2017 | 1640 | 0.290 |
Why?
|
Tissue Distribution | 4 | 2021 | 2263 | 0.280 |
Why?
|
Prodrugs | 2 | 2019 | 259 | 0.270 |
Why?
|
Hydrogen Peroxide | 2 | 2021 | 728 | 0.260 |
Why?
|
Gene Silencing | 4 | 2017 | 1507 | 0.260 |
Why?
|
Membrane Lipids | 1 | 2007 | 251 | 0.260 |
Why?
|
Surface Properties | 5 | 2021 | 1156 | 0.260 |
Why?
|
Genetic Vectors | 1 | 2015 | 3379 | 0.260 |
Why?
|
Tissue Engineering | 2 | 2019 | 1868 | 0.260 |
Why?
|
Nanocapsules | 2 | 2020 | 92 | 0.250 |
Why?
|
Mice, Inbred C57BL | 10 | 2022 | 21990 | 0.250 |
Why?
|
Lung Neoplasms | 2 | 2023 | 13268 | 0.250 |
Why?
|
Neoplasms, Experimental | 3 | 2020 | 1228 | 0.240 |
Why?
|
Protein Interaction Mapping | 1 | 2008 | 617 | 0.240 |
Why?
|
Levodopa | 2 | 2021 | 218 | 0.220 |
Why?
|
Collagen Type IV | 2 | 2021 | 127 | 0.220 |
Why?
|
Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2024 | 117 | 0.220 |
Why?
|
Mice, Inbred BALB C | 4 | 2021 | 6204 | 0.220 |
Why?
|
Brain Ischemia | 1 | 2017 | 3047 | 0.220 |
Why?
|
Anti-Inflammatory Agents | 3 | 2021 | 1795 | 0.210 |
Why?
|
Antineoplastic Agents | 6 | 2020 | 13597 | 0.210 |
Why?
|
Proteins | 4 | 2023 | 6024 | 0.210 |
Why?
|
Thyroid Neoplasms | 1 | 2016 | 2326 | 0.210 |
Why?
|
Melanoma | 1 | 2021 | 5689 | 0.210 |
Why?
|
Humans | 52 | 2024 | 757566 | 0.200 |
Why?
|
Tryptophan | 1 | 2024 | 480 | 0.200 |
Why?
|
Receptors, Aryl Hydrocarbon | 1 | 2024 | 220 | 0.200 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2008 | 803 | 0.190 |
Why?
|
Delayed-Action Preparations | 2 | 2016 | 961 | 0.190 |
Why?
|
Indocyanine Green | 1 | 2023 | 232 | 0.190 |
Why?
|
Putrescine | 1 | 2021 | 42 | 0.190 |
Why?
|
Ornithine Decarboxylase | 1 | 2021 | 64 | 0.190 |
Why?
|
Urease | 1 | 2020 | 39 | 0.180 |
Why?
|
Genes, abl | 1 | 2020 | 69 | 0.180 |
Why?
|
CD8-Positive T-Lymphocytes | 4 | 2022 | 4550 | 0.180 |
Why?
|
Enzymes, Immobilized | 1 | 2020 | 52 | 0.180 |
Why?
|
Oxidative Stress | 3 | 2021 | 3102 | 0.180 |
Why?
|
Dendritic Cells | 3 | 2020 | 2720 | 0.180 |
Why?
|
Endothelial Cells | 2 | 2024 | 3526 | 0.170 |
Why?
|
Xenograft Model Antitumor Assays | 6 | 2019 | 3573 | 0.170 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2020 | 174 | 0.170 |
Why?
|
Hydrodynamics | 1 | 2020 | 167 | 0.160 |
Why?
|
Transfection | 2 | 2018 | 5777 | 0.160 |
Why?
|
Benzylamines | 2 | 2017 | 247 | 0.160 |
Why?
|
Phosphorus | 2 | 2017 | 335 | 0.160 |
Why?
|
Ovalbumin | 1 | 2020 | 672 | 0.160 |
Why?
|
Photosensitizing Agents | 1 | 2023 | 619 | 0.160 |
Why?
|
Silicon Dioxide | 1 | 2019 | 216 | 0.160 |
Why?
|
Benzoates | 2 | 2017 | 210 | 0.150 |
Why?
|
Disease Models, Animal | 7 | 2021 | 18114 | 0.150 |
Why?
|
Autophagy | 2 | 2024 | 1321 | 0.150 |
Why?
|
Infrared Rays | 2 | 2017 | 245 | 0.150 |
Why?
|
Membrane Potentials | 1 | 2021 | 1094 | 0.150 |
Why?
|
Hydroxyl Radical | 1 | 2018 | 83 | 0.150 |
Why?
|
Monocarboxylic Acid Transporters | 1 | 2018 | 80 | 0.150 |
Why?
|
Phototherapy | 2 | 2019 | 368 | 0.150 |
Why?
|
Cisplatin | 3 | 2019 | 1647 | 0.150 |
Why?
|
Osmotic Pressure | 1 | 2018 | 137 | 0.150 |
Why?
|
Methacrylates | 1 | 2017 | 109 | 0.140 |
Why?
|
Polysaccharides, Bacterial | 1 | 2020 | 574 | 0.140 |
Why?
|
Receptors, CXCR4 | 1 | 2022 | 727 | 0.140 |
Why?
|
Genes, Tumor Suppressor | 1 | 2021 | 1055 | 0.140 |
Why?
|
Glutamate Carboxypeptidase II | 1 | 2017 | 80 | 0.140 |
Why?
|
Molecular Structure | 2 | 2020 | 1862 | 0.140 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2015 | 5272 | 0.140 |
Why?
|
Bone Regeneration | 1 | 2019 | 432 | 0.140 |
Why?
|
Motion | 1 | 2020 | 779 | 0.140 |
Why?
|
Antibodies | 2 | 2019 | 2420 | 0.130 |
Why?
|
X-Linked Inhibitor of Apoptosis Protein | 1 | 2016 | 60 | 0.130 |
Why?
|
Peptides | 2 | 2019 | 4338 | 0.130 |
Why?
|
Tissue Scaffolds | 2 | 2019 | 925 | 0.130 |
Why?
|
Ferric Compounds | 1 | 2018 | 377 | 0.130 |
Why?
|
Quantum Dots | 1 | 2017 | 167 | 0.130 |
Why?
|
Ligands | 2 | 2017 | 3257 | 0.130 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2020 | 685 | 0.130 |
Why?
|
Fluorescent Antibody Technique | 1 | 2019 | 2469 | 0.130 |
Why?
|
Protein Engineering | 1 | 2019 | 541 | 0.120 |
Why?
|
Glutarates | 1 | 2017 | 243 | 0.120 |
Why?
|
Azepines | 1 | 2017 | 329 | 0.120 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2019 | 675 | 0.120 |
Why?
|
Drug Resistance, Neoplasm | 4 | 2020 | 5253 | 0.120 |
Why?
|
Endosomes | 1 | 2018 | 519 | 0.120 |
Why?
|
Transforming Growth Factor beta | 1 | 2023 | 1956 | 0.120 |
Why?
|
Boronic Acids | 2 | 2021 | 914 | 0.120 |
Why?
|
Fibronectins | 1 | 2018 | 722 | 0.120 |
Why?
|
Receptors, LDL | 1 | 2017 | 485 | 0.120 |
Why?
|
Endocytosis | 1 | 2019 | 958 | 0.120 |
Why?
|
Pharmacokinetics | 1 | 2014 | 86 | 0.120 |
Why?
|
Molecular Targeted Therapy | 2 | 2018 | 2796 | 0.110 |
Why?
|
Interleukin-10 | 2 | 2021 | 1173 | 0.110 |
Why?
|
Chlamydia trachomatis | 1 | 2015 | 239 | 0.110 |
Why?
|
Protein Binding | 5 | 2021 | 9312 | 0.110 |
Why?
|
Reference Standards | 1 | 2017 | 1003 | 0.110 |
Why?
|
Gold | 2 | 2017 | 479 | 0.110 |
Why?
|
Hydrophobic and Hydrophilic Interactions | 3 | 2021 | 398 | 0.110 |
Why?
|
Cells | 1 | 2014 | 164 | 0.110 |
Why?
|
Bacterial Vaccines | 1 | 2015 | 401 | 0.110 |
Why?
|
Polyglycolic Acid | 1 | 2014 | 405 | 0.110 |
Why?
|
Oxygen | 2 | 2021 | 4190 | 0.100 |
Why?
|
Antigens, Surface | 1 | 2017 | 1607 | 0.100 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2019 | 3799 | 0.100 |
Why?
|
Inflammation | 4 | 2024 | 10709 | 0.100 |
Why?
|
Muscle Proteins | 1 | 2018 | 1150 | 0.100 |
Why?
|
Doxorubicin | 1 | 2019 | 2211 | 0.100 |
Why?
|
Equipment Design | 1 | 2020 | 3502 | 0.100 |
Why?
|
Male | 13 | 2022 | 358180 | 0.100 |
Why?
|
Adjuvants, Immunologic | 2 | 2015 | 1036 | 0.100 |
Why?
|
Chlamydia Infections | 1 | 2015 | 365 | 0.100 |
Why?
|
Molecular Imaging | 1 | 2018 | 813 | 0.100 |
Why?
|
Uterus | 1 | 2015 | 649 | 0.090 |
Why?
|
Vaccines, Synthetic | 1 | 2014 | 617 | 0.090 |
Why?
|
Collagen | 1 | 2019 | 2634 | 0.090 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2021 | 3757 | 0.090 |
Why?
|
Mice, SCID | 1 | 2016 | 2625 | 0.090 |
Why?
|
Enzyme Inhibitors | 1 | 2021 | 3709 | 0.090 |
Why?
|
Biological Transport | 1 | 2015 | 2081 | 0.090 |
Why?
|
Disulfides | 3 | 2018 | 465 | 0.090 |
Why?
|
Aptamers, Nucleotide | 1 | 2012 | 162 | 0.090 |
Why?
|
Mice, Knockout | 3 | 2021 | 14345 | 0.090 |
Why?
|
Cysteine | 1 | 2015 | 892 | 0.090 |
Why?
|
Th1 Cells | 1 | 2015 | 1031 | 0.090 |
Why?
|
Vaccination | 2 | 2020 | 3354 | 0.090 |
Why?
|
Nasopharyngeal Neoplasms | 1 | 2012 | 287 | 0.090 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2018 | 2443 | 0.090 |
Why?
|
Transplantation, Heterologous | 1 | 2018 | 2378 | 0.080 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2022 | 2294 | 0.080 |
Why?
|
Iron | 1 | 2018 | 1785 | 0.080 |
Why?
|
Tumor Cells, Cultured | 1 | 2017 | 6128 | 0.080 |
Why?
|
Lactic Acid | 1 | 2014 | 1133 | 0.080 |
Why?
|
Phosphatidylinositol 3-Kinases | 1 | 2018 | 2859 | 0.080 |
Why?
|
Hyperthermia, Induced | 1 | 2012 | 416 | 0.080 |
Why?
|
Lipid Metabolism | 1 | 2017 | 1895 | 0.080 |
Why?
|
Immunologic Memory | 1 | 2015 | 1353 | 0.080 |
Why?
|
Borates | 1 | 2008 | 19 | 0.080 |
Why?
|
Pyrazines | 1 | 2014 | 1198 | 0.080 |
Why?
|
Signal Transduction | 2 | 2024 | 23335 | 0.080 |
Why?
|
Cell Proliferation | 3 | 2021 | 10405 | 0.080 |
Why?
|
Silicates | 1 | 2008 | 47 | 0.080 |
Why?
|
Liver | 2 | 2021 | 7502 | 0.080 |
Why?
|
Oxidation-Reduction | 3 | 2020 | 2223 | 0.070 |
Why?
|
Haptens | 1 | 2008 | 163 | 0.070 |
Why?
|
Contrast Media | 1 | 2021 | 5297 | 0.070 |
Why?
|
Antigen-Antibody Reactions | 1 | 2008 | 346 | 0.070 |
Why?
|
Glass | 1 | 2008 | 115 | 0.070 |
Why?
|
Microscopy, Atomic Force | 1 | 2008 | 247 | 0.070 |
Why?
|
Cells, Cultured | 5 | 2021 | 18936 | 0.070 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2016 | 2052 | 0.070 |
Why?
|
Liver Neoplasms | 1 | 2022 | 4314 | 0.070 |
Why?
|
Glutathione | 2 | 2018 | 581 | 0.060 |
Why?
|
Cell Cycle Proteins | 1 | 2017 | 3434 | 0.060 |
Why?
|
Models, Chemical | 1 | 2008 | 610 | 0.060 |
Why?
|
Epithelial Cells | 1 | 2017 | 3664 | 0.060 |
Why?
|
Protein Kinase Inhibitors | 1 | 2020 | 5638 | 0.060 |
Why?
|
Kynurenine | 1 | 2024 | 139 | 0.060 |
Why?
|
DNA | 2 | 2020 | 7200 | 0.060 |
Why?
|
Treatment Outcome | 3 | 2021 | 64242 | 0.060 |
Why?
|
Drug Therapy, Combination | 1 | 2013 | 6292 | 0.050 |
Why?
|
Transforming Growth Factors | 1 | 2023 | 75 | 0.050 |
Why?
|
Rabbits | 2 | 2019 | 4772 | 0.050 |
Why?
|
Cattle | 1 | 2008 | 3846 | 0.050 |
Why?
|
Nuclear Proteins | 1 | 2017 | 5786 | 0.050 |
Why?
|
Receptors, Fibroblast Growth Factor | 1 | 2023 | 191 | 0.050 |
Why?
|
Antigen Presentation | 1 | 2008 | 1254 | 0.050 |
Why?
|
Bone Neoplasms | 1 | 2014 | 2524 | 0.050 |
Why?
|
Hypoglycemic Agents | 1 | 2014 | 3069 | 0.050 |
Why?
|
Microfluidics | 1 | 2007 | 652 | 0.050 |
Why?
|
Ubiquitins | 1 | 2023 | 366 | 0.050 |
Why?
|
Cholesterol | 2 | 2022 | 2901 | 0.050 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2010 | 2198 | 0.050 |
Why?
|
Basement Membrane | 1 | 2021 | 348 | 0.050 |
Why?
|
Microscopy, Fluorescence | 1 | 2008 | 2646 | 0.040 |
Why?
|
Rats | 1 | 2017 | 23676 | 0.040 |
Why?
|
Drug Compounding | 1 | 2021 | 245 | 0.040 |
Why?
|
Female | 8 | 2022 | 389943 | 0.040 |
Why?
|
Cytoplasm | 2 | 2018 | 1513 | 0.040 |
Why?
|
Anti-Retroviral Agents | 1 | 2010 | 1780 | 0.040 |
Why?
|
Insulin | 1 | 2014 | 6578 | 0.040 |
Why?
|
Adenocarcinoma | 1 | 2017 | 6323 | 0.040 |
Why?
|
Aptamers, Peptide | 1 | 2018 | 28 | 0.040 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2024 | 730 | 0.040 |
Why?
|
Porosity | 1 | 2019 | 348 | 0.040 |
Why?
|
Immunoglobulins | 1 | 2002 | 859 | 0.040 |
Why?
|
Biomimetics | 1 | 2019 | 173 | 0.040 |
Why?
|
Biomimetic Materials | 1 | 2019 | 172 | 0.040 |
Why?
|
Drug Resistance, Multiple | 1 | 2019 | 253 | 0.040 |
Why?
|
Gene Knockout Techniques | 1 | 2021 | 802 | 0.040 |
Why?
|
Molybdenum | 1 | 2017 | 46 | 0.040 |
Why?
|
Transcription Factors | 1 | 2017 | 12092 | 0.040 |
Why?
|
Coated Materials, Biocompatible | 1 | 2019 | 311 | 0.040 |
Why?
|
Free Radical Scavengers | 1 | 2018 | 211 | 0.040 |
Why?
|
Joints | 1 | 2019 | 321 | 0.040 |
Why?
|
Cell Survival | 2 | 2019 | 5781 | 0.040 |
Why?
|
Apolipoproteins E | 1 | 2023 | 1436 | 0.040 |
Why?
|
Fibroblast Growth Factors | 1 | 2023 | 866 | 0.030 |
Why?
|
Finite Element Analysis | 1 | 2019 | 428 | 0.030 |
Why?
|
Graphite | 1 | 2017 | 76 | 0.030 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2019 | 714 | 0.030 |
Why?
|
Multiple Myeloma | 1 | 2014 | 5129 | 0.030 |
Why?
|
Th17 Cells | 1 | 2022 | 785 | 0.030 |
Why?
|
Amides | 1 | 2018 | 447 | 0.030 |
Why?
|
Anisotropy | 1 | 2019 | 1278 | 0.030 |
Why?
|
Inhibitor of Apoptosis Proteins | 1 | 2016 | 196 | 0.030 |
Why?
|
Spectrum Analysis | 1 | 2017 | 451 | 0.030 |
Why?
|
Cartilage | 1 | 2019 | 806 | 0.030 |
Why?
|
Caco-2 Cells | 1 | 2016 | 364 | 0.030 |
Why?
|
Skull | 1 | 2019 | 815 | 0.030 |
Why?
|
Integrin alpha Chains | 1 | 2015 | 95 | 0.030 |
Why?
|
Vaccines, Inactivated | 1 | 2015 | 179 | 0.030 |
Why?
|
Mass Spectrometry | 1 | 2002 | 2190 | 0.030 |
Why?
|
Immunoconjugates | 1 | 2002 | 949 | 0.030 |
Why?
|
Cytokines | 2 | 2022 | 7336 | 0.030 |
Why?
|
Orphan Nuclear Receptors | 1 | 2014 | 63 | 0.030 |
Why?
|
Chondrocytes | 1 | 2019 | 791 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 2 | 2018 | 36270 | 0.030 |
Why?
|
MAP Kinase Signaling System | 1 | 2021 | 1477 | 0.030 |
Why?
|
Cell Differentiation | 2 | 2022 | 11469 | 0.030 |
Why?
|
Toll-Like Receptor 8 | 1 | 2014 | 99 | 0.030 |
Why?
|
Intracellular Space | 1 | 2014 | 197 | 0.030 |
Why?
|
KB Cells | 1 | 2012 | 13 | 0.030 |
Why?
|
Alendronate | 1 | 2014 | 172 | 0.030 |
Why?
|
Fluorescence Resonance Energy Transfer | 1 | 2015 | 418 | 0.030 |
Why?
|
Toll-Like Receptor 7 | 1 | 2014 | 177 | 0.030 |
Why?
|
Osteogenesis | 1 | 2019 | 1271 | 0.030 |
Why?
|
Toll-Like Receptor 9 | 1 | 2014 | 234 | 0.030 |
Why?
|
Platinum | 1 | 2013 | 219 | 0.030 |
Why?
|
Oligodeoxyribonucleotides | 1 | 2014 | 777 | 0.020 |
Why?
|
Luciferases | 1 | 2013 | 714 | 0.020 |
Why?
|
Taxoids | 1 | 2015 | 666 | 0.020 |
Why?
|
Mucous Membrane | 1 | 2015 | 657 | 0.020 |
Why?
|
Peritonitis | 1 | 2014 | 369 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2019 | 20992 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2008 | 7840 | 0.020 |
Why?
|
Oligopeptides | 1 | 2016 | 1184 | 0.020 |
Why?
|
Histones | 1 | 2021 | 2570 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2014 | 2013 | 0.020 |
Why?
|
Ultraviolet Rays | 1 | 2015 | 1077 | 0.020 |
Why?
|
Regeneration | 1 | 2019 | 1505 | 0.020 |
Why?
|
Triglycerides | 1 | 2017 | 2450 | 0.020 |
Why?
|
Antibody Formation | 1 | 2014 | 1397 | 0.020 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 2022 | 3069 | 0.020 |
Why?
|
Mesenchymal Stem Cells | 1 | 2019 | 1631 | 0.020 |
Why?
|
Lymph Nodes | 1 | 2020 | 3470 | 0.020 |
Why?
|
Antigens | 1 | 2014 | 1445 | 0.020 |
Why?
|
Immunity, Cellular | 1 | 2014 | 1557 | 0.020 |
Why?
|
Temperature | 1 | 2014 | 2217 | 0.020 |
Why?
|
Imidazoles | 1 | 2014 | 1178 | 0.020 |
Why?
|
Spleen | 1 | 2014 | 2295 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2020 | 4350 | 0.020 |
Why?
|
T-Lymphocyte Subsets | 1 | 2015 | 1806 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2016 | 4257 | 0.020 |
Why?
|
Phenotype | 1 | 2024 | 16533 | 0.020 |
Why?
|
Antigens, CD | 1 | 2015 | 3996 | 0.010 |
Why?
|
Models, Biological | 1 | 2021 | 9459 | 0.010 |
Why?
|
Biomedical Research | 1 | 2019 | 3415 | 0.010 |
Why?
|
HIV Infections | 1 | 2010 | 17270 | 0.010 |
Why?
|
Communicable Disease Control | 1 | 2010 | 842 | 0.010 |
Why?
|
Gold Colloid | 1 | 2002 | 12 | 0.010 |
Why?
|
Gene Expression | 1 | 2014 | 7584 | 0.010 |
Why?
|
Carcinoma | 1 | 2012 | 2330 | 0.010 |
Why?
|
Gene Expression Regulation | 1 | 2019 | 11890 | 0.010 |
Why?
|
Cell Line | 1 | 2014 | 15587 | 0.010 |
Why?
|
Binding Sites | 1 | 2008 | 6034 | 0.010 |
Why?
|
Immunoassay | 1 | 2002 | 746 | 0.010 |
Why?
|
Computer Simulation | 1 | 2008 | 6198 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2018 | 58558 | 0.010 |
Why?
|
Aged | 1 | 2018 | 167890 | 0.000 |
Why?
|
Middle Aged | 1 | 2018 | 219192 | 0.000 |
Why?
|
Adult | 1 | 2018 | 219725 | 0.000 |
Why?
|